Blurred or Distorted Central Vision: Causes and Care
Understanding Blurred and Distorted Central Vision
Central vision is what you use to see objects directly in front of you. It allows you to read text, thread a needle, drive, and recognize the faces of people you know. The macula is responsible for this sharp, detailed sight. When the macula is damaged or swollen, central vision becomes blurry, wavy, or may develop blank spots.
When fluid leaks into or under the macula, or when cells in the macula break down, central vision suffers. You may notice that straight lines appear wavy, a condition called metamorphopsia (distorted vision). Some people see a blank or dark spot in the center of their visual field, known as a scotoma. The more swelling or damage present, the more noticeable these symptoms become. If left untreated, chronic swelling of the macula, called macular edema, can lead to permanent vision loss.
Blurred or distorted central vision is not a normal part of aging that should be ignored. It is often a sign that something is happening inside the eye that needs medical evaluation. Several serious retinal conditions share this symptom, and only a thorough eye exam can determine the cause. Early treatment for most of these conditions leads to better outcomes than waiting until vision loss becomes severe.
Common Causes of Blurred or Distorted Central Vision
Age-related macular degeneration (AMD) is the leading cause of central vision loss among older Americans. In 2019, an estimated 18.34 million people in the United States aged 40 and older were living with early-stage AMD, and about 1.49 million had late-stage AMD (PMC, 2022). AMD occurs as yellow deposits called drusen form under the retina during normal aging. Over time, these deposits can damage the light-sensitive cells in the macula.
There are two forms of AMD. Dry AMD is the more common type and involves a gradual breakdown of macular cells. Wet AMD is less common but more severe. It occurs when abnormal blood vessels grow beneath the retina and leak fluid or blood, causing rapid central vision changes. Distorted or blurred central vision is a hallmark symptom of wet AMD.
Diabetic macular edema (DME) is a complication of diabetic retinopathy, a condition caused by diabetes-related damage to the blood vessels in the retina. Damaged blood vessels leak fluid into the macula, causing it to swell. This swelling blurs and distorts central vision. The prevalence of DME among United States adults with diabetes aged 40 and older is approximately 3.8%, affecting an estimated 746,000 people (PMC, 2015). DME can develop at any stage of diabetic retinopathy and requires prompt treatment to prevent permanent damage.
A retinal vein occlusion (RVO) occurs when a vein that carries blood away from the retina becomes blocked. This blockage causes blood and fluid to leak into the retina, often affecting the macula. Central retinal vein occlusion (CRVO) affects approximately 0.8 per 1,000 people based on pooled population studies from the United States, Europe, Asia, and Australia (NCBI, StatPearls). Patients with CRVO often describe sudden blurry or distorted vision in one eye. The blockage is related to factors such as hardening of the arteries, high blood pressure, and conditions that increase blood clotting.
Central serous chorioretinopathy (CSC) is a condition in which fluid collects under the retina, creating a small detachment that affects central vision. CSC most often occurs in young and middle-aged adults and is more common in men. Blurry central vision in one eye is the most typical symptom. The exact causes of CSC are not fully understood, but corticosteroid use, emotional stress, and certain personality traits have been linked to the condition. Corticosteroids are found in many common products, including allergy nasal sprays and anti-inflammatory skin creams.
A macular hole is a small break in the macula that causes blurred and distorted central vision. An epiretinal membrane (a thin layer of scar tissue on the macula surface) can also pull on the macula and cause visual distortion. Both conditions may develop as a complication of posterior vitreous detachment (PVD), a common age-related change in which the gel inside the eye separates from the retina. If PVD leads to a macular hole or epiretinal membrane, decreased or distorted vision may develop along with floaters and flashes of light.
Who Is at Risk
Age is the single greatest risk factor for many conditions that cause blurred central vision. AMD affects one in eight people aged 60 and older, and the prevalence rises sharply after age 80. More than 15 percent of white women older than 80 have advanced forms of AMD (NEI). AMD is also far more prevalent among white individuals than among Black individuals. CRVO typically occurs in people aged 50 and older. CSC, in contrast, tends to affect younger adults, usually between the ages of 20 and 50.
Several medical conditions raise the risk of developing retinal problems that affect central vision. These include:
- Diabetes mellitus, which can lead to diabetic retinopathy and diabetic macular edema
- High blood pressure, a major risk factor for retinal vein occlusion
- Kidney disease, which is associated with increased risk for CRVO
- Glaucoma, which has been linked to a higher risk of retinal vein occlusion
- Arteriosclerosis (hardening of the arteries), which can compress retinal veins
Systemic corticosteroid use can trigger or worsen CSC. This includes prescription corticosteroids as well as over-the-counter products like allergy nasal sprays and anti-inflammatory skin creams. Emotional stress and type A personality traits have also been associated with CSC. For diabetic retinopathy, poor blood sugar control, longer duration of diabetes, and high blood pressure all increase the risk of developing macular edema and vision-threatening disease.
Signs and Symptoms to Watch For
Some conditions cause central vision to blur slowly over weeks or months. You may first notice difficulty reading small print or recognizing faces at a distance. Colors may appear faded or less vivid. Straight lines, such as doorframes or telephone poles, may start to look bent or wavy. These gradual changes are common in dry AMD and early diabetic macular edema.
Sudden blurring or distortion in one eye demands immediate attention. Wet AMD, retinal vein occlusion, and some cases of CSC can cause rapid changes in central vision. If you experience a sudden increase in floaters, flashes of light, a curtain or shadow across your vision, or sudden vision loss in one eye, see a retina specialist or go to the emergency room immediately. These symptoms may indicate a retinal emergency.
Metamorphopsia, or visual distortion, is a signature symptom of macular disease. Words on a page may appear jumbled or wavy. A grid pattern, such as bathroom tiles, may look warped. You may also develop a scotoma, a blank or dark area in the center of your visual field. These symptoms can affect your ability to drive, read, and perform everyday tasks safely.
Diagnosis and Testing
A retina specialist will begin with a comprehensive dilated eye exam. Special eye drops widen the pupil, allowing the specialist to examine the retina and macula in detail using a bright light and magnifying lenses. This exam can reveal drusen, fluid buildup, abnormal blood vessels, retinal swelling, and other signs of disease.
Optical coherence tomography (OCT) is a noninvasive imaging test that creates detailed cross-sectional pictures of the retina. It can measure the thickness of the macula and detect fluid under or within the retinal layers. OCT is one of the most important tools for diagnosing and monitoring conditions like macular edema, AMD, and CSC. This scan takes only a few minutes and does not require any injections.
Fluorescein angiography involves injecting a yellow dye into a vein in the arm. As the dye travels through the blood vessels in the retina, a special camera captures images. This test helps a retina specialist identify leaking blood vessels, areas of poor blood flow, and abnormal new vessel growth. It is particularly useful for diagnosing diabetic retinopathy, retinal vein occlusion, and wet AMD.
An Amsler grid is a simple tool that looks like a sheet of graph paper with a dot in the center. You can use it at home to monitor your central vision. While looking at the dot, you check whether any of the lines appear wavy, broken, or missing. Changes on the Amsler grid can be an early sign of macular disease and should prompt an appointment with a retina specialist.
Treatment Options
Anti-VEGF (anti-vascular endothelial growth factor) injections are the most common treatment for conditions that cause macular edema and abnormal blood vessel growth. These medications are injected directly into the eye, a procedure called an intravitreal injection. They block a protein called VEGF that drives abnormal vessel growth and fluid leakage.
Commonly used anti-VEGF medications include Eylea (aflibercept), typically given every 4 to 8 weeks after initial loading doses, and Lucentis (ranibizumab), often given every 4 weeks. Eylea HD (high-dose aflibercept) may allow extended intervals of 8 to 16 weeks after loading doses. Vabysmo (faricimab), a bispecific antibody, targets two different pathways and can be given every 4 to 16 weeks. Avastin (bevacizumab) is also widely used, though it is important to note that Avastin is FDA-approved for cancer treatment and is used off-label for eye conditions. Large, well-designed clinical trials have shown it to be effective for macular edema.
For some patients, corticosteroid implants may be recommended to reduce macular swelling. Ozurdex (dexamethasone implant) is a small device injected into the eye that slowly releases anti-inflammatory medication over several months. Iluvien (fluocinolone acetonide implant) provides sustained release over a longer period. These options may be considered when anti-VEGF injections alone do not adequately control swelling, or when a patient has difficulty with frequent injection visits.
Laser photocoagulation (thermal laser treatment) was once the standard approach for macular edema and diabetic retinopathy. While anti-VEGF injections have largely replaced laser for macular edema, laser treatment still plays a role in managing peripheral retinal disease and certain cases of diabetic retinopathy. Data from 2009 to 2018 show that claims for laser photocoagulation decreased by 68 percent among patients with DME, while anti-VEGF injection claims increased by 327 percent (AAPC trend analysis).
For chronic central serous chorioretinopathy, photodynamic therapy (PDT) is often an effective treatment. During PDT, a light-sensitive drug called verteporfin is injected into a vein in the arm. The drug travels to the eye, where a retina specialist activates it using a special cold laser directed at the area of fluid leakage under the retina. This treatment helps seal the source of leakage and allows the fluid to absorb. Thermal laser and oral medications are also sometimes used for CSC.
If a macular hole is causing blurred or distorted central vision, a vitrectomy (a surgery to remove the gel inside the eye) may be recommended. During the procedure, the retina specialist removes the vitreous gel and places a gas bubble inside the eye. The bubble presses against the macula to help the hole close. Face-down positioning after surgery is typically required for a period of days to weeks to keep the bubble in the correct position.
What to Expect
Most diagnostic tests for central vision changes are quick and performed in an office setting. Dilated eye exams and OCT scans are painless. Fluorescein angiography involves a brief needle stick in the arm and may cause temporary yellowing of the skin and urine. Some patients feel mild nausea during the dye injection, but this passes quickly.
Intravitreal injections are performed in the office under local anesthesia. The eye is numbed with drops, and the injection is given through the white part of the eye. Most patients report feeling pressure rather than sharp pain, though some discomfort is normal. After the injection, mild redness, irritation, and floaters in the treated eye are common and usually resolve within a few days. Your retina specialist will discuss the expected treatment schedule, which may involve repeated injections over many months.
Many retinal conditions that cause blurred central vision require ongoing treatment. Anti-VEGF injections are often given on a regular schedule, with the interval adjusted based on how the eye responds. Some patients need monthly injections at first, with longer gaps between treatments over time. Others may need sustained treatment for years. For CSC, many cases resolve on their own, but chronic CSC may require photodynamic therapy or other interventions. Your retina specialist will tailor your treatment plan based on your specific diagnosis and response.
Living with Central Vision Changes
Regularly checking your vision at home can help detect new changes early. An Amsler grid is a helpful tool for this purpose. Cover one eye at a time and look at the grid in good lighting. If you notice new waviness, blurriness, or missing areas, contact a retina specialist promptly. Checking each eye separately is important because one eye may compensate for the other, masking problems.
Low vision aids can help you make the most of your remaining vision. Large-print books, magnifying glasses, high-contrast settings on phones and computers, and audiobooks can make daily activities easier. Adjusting lighting in your home, using bright task lamps for reading, and reducing glare can also improve visual comfort. An occupational therapist or low vision specialist can recommend additional tools and strategies.
Vision changes can cause frustration, anxiety, and a sense of loss. These feelings are normal and valid. Support groups, counseling, and connecting with others who have similar experiences can be helpful. Many national organizations offer resources for people living with vision loss. Staying engaged in social activities and hobbies, even with modifications, supports mental and emotional health.
When to See a Retina Specialist
Certain symptoms require immediate evaluation. See a retina specialist or go to the emergency room immediately if you experience any of the following:
- Sudden blurring or loss of central vision in one eye
- A sudden increase in floaters or flashes of light
- A curtain, shadow, or dark area moving across your vision
- New distortion where straight lines appear wavy or bent
Even if symptoms develop gradually, they should not be dismissed. If you notice progressive difficulty reading, recognizing faces, or seeing fine details, schedule an evaluation with a retina specialist. People with diabetes should have annual dilated eye exams to screen for diabetic retinopathy and macular edema. Those with a family history of AMD or other retinal conditions may benefit from earlier or more frequent screening.
Many retinal conditions that cause central vision changes respond best to treatment when caught early. Once significant macular damage has occurred, it may not be fully reversible. Regular eye exams and prompt attention to new visual symptoms give you the best chance of preserving your central vision over the long term.
Questions and Answers
In many cases, treatment can improve blurred central vision, especially when started early. Anti-VEGF injections can reduce macular swelling and, in some patients, lead to measurable vision improvement. However, if the macula has sustained significant damage before treatment begins, some vision loss may be permanent. The goal of treatment is to stabilize vision and prevent further decline.
Yes. Some retinal conditions can be present without obvious symptoms, especially in the early stages. Early AMD may cause no noticeable vision changes. CSC that affects areas outside the central macula may not be noticeable. Diabetic retinopathy can progress significantly before symptoms appear. This is why routine dilated eye exams are important, particularly for people with diabetes or those over age 60.
Anti-VEGF injections deliver medication directly into the eye to block the protein responsible for abnormal blood vessel growth and fluid leakage. Laser treatment uses focused light energy to seal leaking vessels or destroy abnormal tissue. Anti-VEGF injections have largely replaced laser as the primary treatment for macular edema because they tend to preserve more vision and cause less collateral damage to healthy retinal tissue. However, laser still has a role in certain situations, such as treating areas of the peripheral retina in diabetic retinopathy.
Stress has been linked to central serous chorioretinopathy (CSC). It is thought that the body may produce natural corticosteroids during periods of high stress, which can trigger fluid buildup under the retina in people who are prone to CSC. While stress management alone may not prevent CSC, reducing stress and avoiding unnecessary corticosteroid use may lower the risk of episodes. If you develop sudden blurry vision during a stressful period, a retina specialist can evaluate whether CSC is the cause.
The frequency of visits depends on your specific diagnosis and how your eyes respond to treatment. Many patients receiving anti-VEGF injections start with monthly visits and may transition to longer intervals as the condition stabilizes. Some patients need treatment for many months or years. Your retina specialist will develop a personalized schedule and adjust it based on imaging results and visual acuity at each visit. Keeping all scheduled appointments is important for the best possible outcome.